BioRem Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for BioRem.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Commercial Services earnings growth | 82.1% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)
Oct 11
Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)
Apr 19BioRem Inc. (CVE:BRM) Soars 35% But It's A Story Of Risk Vs Reward
Apr 12BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet
Jan 25Is BioRem (CVE:BRM) Using Too Much Debt?
Aug 26Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly
Mar 23BioRem (CVE:BRM) Could Easily Take On More Debt
Aug 25These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well
May 20Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital
Jan 26Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque
Nov 23
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as BioRem has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 40 | 5 | 5 | 5 | N/A |
| 6/30/2024 | 31 | 4 | 4 | 5 | N/A |
| 3/31/2024 | 28 | 3 | 3 | 4 | N/A |
| 12/31/2023 | 25 | 2 | 0 | 0 | N/A |
| 9/30/2023 | 24 | 1 | 2 | 3 | N/A |
| 6/30/2023 | 26 | 1 | -2 | -1 | N/A |
| 3/31/2023 | 28 | 1 | 3 | 3 | N/A |
| 12/31/2022 | 29 | 2 | 1 | 1 | N/A |
| 9/30/2022 | 29 | 2 | 2 | 2 | N/A |
| 6/30/2022 | 26 | 2 | 3 | 3 | N/A |
| 3/31/2022 | 25 | 2 | 2 | 2 | N/A |
| 12/31/2021 | 24 | 1 | 4 | 4 | N/A |
| 9/30/2021 | 22 | 1 | 0 | 1 | N/A |
| 6/30/2021 | 21 | 1 | 3 | 3 | N/A |
| 3/31/2021 | 21 | 1 | 5 | 5 | N/A |
| 12/31/2020 | 24 | 2 | 3 | 3 | N/A |
| 9/30/2020 | 21 | -1 | 4 | 4 | N/A |
| 6/30/2020 | 23 | -1 | 2 | 2 | N/A |
| 3/31/2020 | 23 | -1 | -1 | 0 | N/A |
| 12/31/2019 | 21 | -1 | 2 | 3 | N/A |
| 9/30/2019 | 27 | 5 | 2 | 2 | N/A |
| 6/30/2019 | 25 | 5 | 2 | 2 | N/A |
| 3/31/2019 | 25 | 5 | 1 | 1 | N/A |
| 12/31/2018 | 24 | 5 | 0 | 0 | N/A |
| 9/30/2018 | 22 | 1 | 1 | 1 | N/A |
| 6/30/2018 | 23 | 2 | N/A | 1 | N/A |
| 3/31/2018 | 23 | 1 | N/A | 1 | N/A |
| 12/31/2017 | 23 | 2 | N/A | 1 | N/A |
| 9/30/2017 | 19 | 1 | N/A | 1 | N/A |
| 6/30/2017 | 18 | 0 | N/A | 0 | N/A |
| 3/31/2017 | 15 | 0 | N/A | 2 | N/A |
| 12/31/2016 | 16 | 1 | N/A | -1 | N/A |
| 9/30/2016 | 14 | 1 | N/A | 0 | N/A |
| 6/30/2016 | 15 | 1 | N/A | 1 | N/A |
| 3/31/2016 | 16 | 2 | N/A | 2 | N/A |
| 12/31/2015 | 17 | 2 | N/A | 2 | N/A |
| 9/30/2015 | 18 | 2 | N/A | 2 | N/A |
| 6/30/2015 | 16 | 1 | N/A | 2 | N/A |
| 3/31/2015 | 13 | -1 | N/A | 1 | N/A |
| 12/31/2014 | 11 | -2 | N/A | 0 | N/A |
| 9/30/2014 | 12 | -1 | N/A | 0 | N/A |
| 6/30/2014 | 15 | -1 | N/A | 0 | N/A |
| 3/31/2014 | 17 | 0 | N/A | 0 | N/A |
| 12/31/2013 | 20 | 1 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BRM's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if BRM's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if BRM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BRM's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if BRM's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BRM's Return on Equity is forecast to be high in 3 years time